Deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunity
Science, Volume 389, Issue 6767, Page 1347-1352, September 2025.
Global Helium Industry Intelligence
Science, Volume 389, Issue 6767, Page 1347-1352, September 2025.
Leave a Reply